Abstract Iron deficiency anemia affects> 1.2 billions individuals worldwide, and iron
deficiency in the absence of anemia is even more frequent. Total-body (absolute) iron …

Allergists and clinical immunologists around the world are increasingly faced with the task of
addressing drug allergy and hypersensitivity due to the increase in drug reactions …

Iron deficiency anaemia (IDA) currently affects 1.2 billion people and iron deficiency without
anaemia (IDWA) is at least twice as common. IDWA is poorly recognised by clinicians …

Iron deficiency anemia is the most common and most treatable of all anemias. There is an
evolving understanding that iron deficiency can lead to symptoms independent of anemia …

Anemia is very common in patients with inflammatory disorders. Its prevalence is associated
with severity of the underlying disease, and it negatively affects quality of life and cardio …

Despite numerous guidelines on the management of anaemia in surgical patients, there is
no pragmatic guidance for the diagnosis and management of anaemia and iron deficiency in …

Iron deficiency, with or without anemia, is extremely frequent worldwide, representing a
major public health problem. Iron replacement therapy dates back to the seventeenth …

Anemia is common in the perioperative period and is associated with poor patient outcomes.
Remarkably, anemia is frequently ignored until hemoglobin levels drop low enough to …

Background Rising criticism of currently available contrast agents for magnetic resonance
imaging, either due to their side effects or limited possibilities in terms of functional imaging …

Introduction: The newest intravenous (IV) iron products show an improved safety profile over
predecessors, allowing for the rapid administration of relatively high doses. Ferric …